146 related articles for article (PubMed ID: 17056639)
1. Rituximab in refractory antineutrophil cytoplasmic antibody-associated vasculitis: what is the current evidence?
Wong CF
Nephrol Dial Transplant; 2007 Jan; 22(1):32-6. PubMed ID: 17056639
[No Abstract] [Full Text] [Related]
2. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
3. Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis: granulomatous disease more resistant than vasculitis disease?
Wong CF
J Clin Rheumatol; 2008 Apr; 14(2):61-4. PubMed ID: 18391671
[No Abstract] [Full Text] [Related]
4. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Flossmann O; Jones RB; Jayne DR; Luqmani RA
Ann Rheum Dis; 2006 Jul; 65(7):841-4. PubMed ID: 16769779
[TBL] [Abstract][Full Text] [Related]
5. Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
Golbin JM; Specks U
Rheum Dis Clin North Am; 2007 Nov; 33(4):741-54, v. PubMed ID: 18037114
[TBL] [Abstract][Full Text] [Related]
6. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
Holle JU; Gross WL
J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
[TBL] [Abstract][Full Text] [Related]
7. Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab.
Clatworthy MR; Jayne DR
Am J Kidney Dis; 2006 Apr; 47(4):680-2. PubMed ID: 16564946
[TBL] [Abstract][Full Text] [Related]
8. Rituximab associated pneumonitis in antineutrophil cytoplasmic antibody-associated vasculitis.
Arulkumaran N; Suleman R; Cecconi M; Kiely P; Chua F
J Clin Rheumatol; 2012 Jan; 18(1):39-41. PubMed ID: 22157278
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin in Wegener's granulomatosis and microscopic polyangiitis.
Langford CA; Hoffman GS
Arthritis Rheum; 2008 Jul; 58(7):2211-2; author reply 2212. PubMed ID: 18576349
[No Abstract] [Full Text] [Related]
10. Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.
Sánchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N
J Clin Rheumatol; 2008 Apr; 14(2):92-3. PubMed ID: 18391678
[TBL] [Abstract][Full Text] [Related]
11. Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future.
Walsh M; Jayne D
Kidney Int; 2007 Sep; 72(6):676-82. PubMed ID: 17609693
[TBL] [Abstract][Full Text] [Related]
12. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
Seo P; Specks U; Keogh KA
J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
[TBL] [Abstract][Full Text] [Related]
14. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
[TBL] [Abstract][Full Text] [Related]
15. Targeting the B cell in vasculitis.
Walsh M; Jayne D
Pediatr Nephrol; 2009 Jul; 24(7):1267-75. PubMed ID: 18931860
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
Bosch X; Guilabert A; Espinosa G; Mirapeix E
Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
[TBL] [Abstract][Full Text] [Related]
17. Refractory Wegener's meningitis treated with rituximab.
Bawa S; Mukhtyar C; Edmonds S; Webley M
J Rheumatol; 2007 Apr; 34(4):900-1. PubMed ID: 17407257
[No Abstract] [Full Text] [Related]
18. Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.
Golbin JM; Specks U
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S74-6. PubMed ID: 17428376
[No Abstract] [Full Text] [Related]
19. Recent advances to achieve remission induction in antineutrophil cytoplasmic antibody-associated vasculitis.
Harper L
Curr Opin Rheumatol; 2010 Jan; 22(1):37-42. PubMed ID: 19770660
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
